{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,13]],"date-time":"2026-02-13T07:50:03Z","timestamp":1770969003641,"version":"3.50.1"},"reference-count":25,"publisher":"BMJ","issue":"2","content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["Br J Ophthalmol"],"published-print":{"date-parts":[[2016,2]]},"DOI":"10.1136\/bjophthalmol-2015-306650","type":"journal-article","created":{"date-parts":[[2015,7,11]],"date-time":"2015-07-11T02:44:53Z","timestamp":1436582693000},"page":"195-199","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":13,"title":["Influence of drug therapy on the risk of recurrence of ocular toxoplasmosis"],"prefix":"10.1136","volume":"100","author":[{"given":"Michael","family":"Reich","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Matthias D","family":"Becker","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Friederike","family":"Mackensen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"239","published-online":{"date-parts":[[2015,7,10]]},"reference":[{"key":"key-10.1136\/bjophthalmol-2015-306650-1","doi-asserted-by":"crossref","first-page":"127","DOI":"10.3899\/jrheum.080102","article-title":"Uveitis subtypes in a German Interdisciplinary Uveitis Center\u2014analysis of 1916 patients","volume":"36","author":"Jakob","year":"2009","journal-title":"J Rheumatol"},{"key":"key-10.1136\/bjophthalmol-2015-306650-2","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/S0002-9394(14)74217-5","article-title":"Changing patterns of uveitis","volume":"103","author":"Henderly","year":"1987","journal-title":"Am J Ophthalmol"},{"key":"key-10.1136\/bjophthalmol-2015-306650-3","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/S0002-9394(14)70532-X","article-title":"Causes of uveitis in the general practice of ophthalmology. UCLA Community-Based Uveitis Study Group","volume":"121","author":"McCannel","year":"1996","journal-title":"Am J Ophthalmol"},{"key":"key-10.1136\/bjophthalmol-2015-306650-4","doi-asserted-by":"crossref","first-page":"68","DOI":"10.3109\/09273948.2012.661115","article-title":"Epidemiology of ocular toxoplasmosis","volume":"20","author":"Petersen","year":"2012","journal-title":"Ocul Immunol Inflamm"},{"key":"key-10.1136\/bjophthalmol-2015-306650-5","first-page":"287","article-title":"Infectious uveitis","volume-title":"Clinical pathways in vitreoretinal disease","author":"Djalilian","year":"2003"},{"key":"key-10.1136\/bjophthalmol-2015-306650-6","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1016\/S0171-2985(99)80065-5","article-title":"Stage differentiation of the protozoan parasite Toxoplasma gondii","volume":"201","author":"Bohne","year":"1999","journal-title":"Immunobiology"},{"key":"key-10.1136\/bjophthalmol-2015-306650-7","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1016\/S0002-9394(02)01526-X","article-title":"An update on current practices in the management of ocular toxoplasmosis","volume":"134","author":"Holland","year":"2002","journal-title":"Am J Ophthalmol"},{"key":"key-10.1136\/bjophthalmol-2015-306650-8","doi-asserted-by":"crossref","first-page":"926","DOI":"10.1016\/S0161-6420(03)00083-6","article-title":"Antibiotics for toxoplasmic retinochoroiditis: an evidence-based systematic review","volume":"110","author":"Stanford","year":"2003","journal-title":"Ophthalmology"},{"key":"key-10.1136\/bjophthalmol-2015-306650-9","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1016\/S0002-9394(14)74456-3","article-title":"Therapy for ocular toxoplasmosis","volume":"115","author":"Rothova","year":"1993","journal-title":"Am J Ophthalmol"},{"key":"key-10.1136\/bjophthalmol-2015-306650-10","first-page":"1","article-title":"Ocular toxoplasmosis: a global reassessment. Part II: disease manifestations and management","volume":"137","author":"Holland","year":"2004","journal-title":"Am J Ophthalmol"},{"key":"key-10.1136\/bjophthalmol-2015-306650-11","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1590\/S0074-02762009000200027","article-title":"Treating ocular toxoplasmosis: current evidence","volume":"104","author":"Stanford","year":"2009","journal-title":"Mem Inst Oswaldo Cruz"},{"key":"key-10.1136\/bjophthalmol-2015-306650-12","first-page":"1183","article-title":"Toxoplasmosis","volume-title":"Ocular infection & immunity","author":"Holland","year":"1996"},{"key":"key-10.1136\/bjophthalmol-2015-306650-13","first-page":"192","article-title":"Manifestations and management of ocular toxoplasmosis","volume":"50","author":"O'Connor","year":"1974","journal-title":"Bull N Y Acad Med"},{"key":"key-10.1136\/bjophthalmol-2015-306650-14","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1007\/BF02306491","article-title":"Therapy of ocular toxoplasmosis","volume":"13","author":"Rothova","year":"1989","journal-title":"Int Ophthalmol"},{"key":"key-10.1136\/bjophthalmol-2015-306650-15","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1001\/archopht.1976.03910030093001","article-title":"Editorial: dangers of steroid treatment in toxoplasmosis. Periocular injections and systemic therapy","volume":"94","author":"O'Connor","year":"1976","journal-title":"Arch Ophthalmol"},{"key":"key-10.1136\/bjophthalmol-2015-306650-16","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1016\/0002-9394(81)90642-5","article-title":"Fulminant ocular toxoplasmosis","volume":"92","author":"Sabates","year":"1981","journal-title":"Am J Ophthalmol"},{"key":"key-10.1136\/bjophthalmol-2015-306650-17","doi-asserted-by":"crossref","first-page":"1001","DOI":"10.1136\/bjo.2008.155861","article-title":"Frequency and factors associated with recurrences of ocular toxoplasmosis in a referral centre in Colombia","volume":"93","author":"de-la-Torre","year":"2009","journal-title":"Br J Ophthalmol"},{"key":"key-10.1136\/bjophthalmol-2015-306650-18","doi-asserted-by":"crossref","first-page":"809","DOI":"10.1097\/IAE.0000000000000361","article-title":"Time patterns of recurrences and factors predisposing for a higher risk of recurrence of ocular toxoplasmosis","volume":"35","author":"Reich","year":"2015","journal-title":"Retina"},{"key":"key-10.1136\/bjophthalmol-2015-306650-19","doi-asserted-by":"crossref","first-page":"1007","DOI":"10.1016\/j.ajo.2008.01.023","article-title":"Analysis of recurrence patterns associated with toxoplasmic retinochoroiditis","volume":"145","author":"Holland","year":"2008","journal-title":"Am J Ophthalmol"},{"key":"key-10.1136\/bjophthalmol-2015-306650-20","doi-asserted-by":"crossref","first-page":"1253","DOI":"10.1136\/bjo.2007.123661","article-title":"Recurrence characteristics in European patients with ocular toxoplasmosis","volume":"92","author":"Garweg","year":"2008","journal-title":"Br J Ophthalmol"},{"key":"key-10.1136\/bjophthalmol-2015-306650-21","doi-asserted-by":"crossref","first-page":"1023","DOI":"10.1007\/s00347-008-1694-2","article-title":"Diagnosis and treatment of ocular toxoplasmosis : a survey of German-speaking ophthalmologists","volume":"105","author":"Torun","year":"2008","journal-title":"Ophthalmologe"},{"key":"key-10.1136\/bjophthalmol-2015-306650-22","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1128\/CMR.11.2.267","article-title":"Structures of Toxoplasma gondii tachyzoites, bradyzoites, and sporozoites and biology and development of tissue cysts","volume":"11","author":"Dubey","year":"1998","journal-title":"Clin Microbiol Rev"},{"key":"key-10.1136\/bjophthalmol-2015-306650-23","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1006\/expr.1999.4421","article-title":"Toxoplasma gondii in primary rat CNS cells: differential contribution of neurons, astrocytes, and microglial cells for the intracerebral development and stage differentiation","volume":"93","author":"Luder","year":"1999","journal-title":"Exp Parasitol"},{"key":"key-10.1136\/bjophthalmol-2015-306650-24","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/S0002-9394(02)01527-1","article-title":"The effect of long-term intermittent trimethoprim\/sulfamethoxazole treatment on recurrences of toxoplasmic retinochoroiditis","volume":"134","author":"Silveira","year":"2002","journal-title":"Am J Ophthalmol"},{"key":"key-10.1136\/bjophthalmol-2015-306650-25","doi-asserted-by":"crossref","first-page":"762","DOI":"10.1016\/j.ajo.2013.12.022","article-title":"Trimethoprim-sulfamethoxazole versus placebo to reduce the risk of recurrences of toxoplasma gondii retinochoroiditis: randomized controlled clinical trial","volume":"157","author":"Felix","year":"2014","journal-title":"Am J Ophthalmol"}],"container-title":["British Journal of Ophthalmology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/bjophthalmol-2015-306650","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,9,26]],"date-time":"2020-09-26T08:50:05Z","timestamp":1601110205000},"score":1,"resource":{"primary":{"URL":"https:\/\/bjo.bmj.com\/lookup\/doi\/10.1136\/bjophthalmol-2015-306650"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,7,10]]},"references-count":25,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2016,1,21]]},"published-print":{"date-parts":[[2016,2]]}},"alternative-id":["10.1136\/bjophthalmol-2015-306650"],"URL":"https:\/\/doi.org\/10.1136\/bjophthalmol-2015-306650","relation":{},"ISSN":["0007-1161","1468-2079"],"issn-type":[{"value":"0007-1161","type":"print"},{"value":"1468-2079","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,7,10]]}}}